Figure 2.
First inhibitor titer (BU/mL) value by EDsa for first LTI and HTI developmentb-e.aBefore inhibitor development or inhibitor progression. bImmune tolerance induction regimen is excluded from this analysis. cTwo patients have no data post LTI/HTI development. dCategorization of titer level requires a positive inhibitor test result followed by a second positive test result 2 to 4 weeks after the original sample was drawn. This analysis is based on the first of the 2 inhibitor readings. The categorization of the patient with LTIs with a value of ∼11 BU at 5 EDs was based on failing to achieve a second repeat inhibitor test above 5 BU/mL needed to confirm HTI classification. eSeven of the patients with HTIs (50%) had previously developed an LTI.

First inhibitor titer (BU/mL) value by EDsa for first LTI and HTI developmentb-e.aBefore inhibitor development or inhibitor progression. bImmune tolerance induction regimen is excluded from this analysis. cTwo patients have no data post LTI/HTI development. dCategorization of titer level requires a positive inhibitor test result followed by a second positive test result 2 to 4 weeks after the original sample was drawn. This analysis is based on the first of the 2 inhibitor readings. The categorization of the patient with LTIs with a value of ∼11 BU at 5 EDs was based on failing to achieve a second repeat inhibitor test above 5 BU/mL needed to confirm HTI classification. eSeven of the patients with HTIs (50%) had previously developed an LTI.

Close Modal

or Create an Account

Close Modal
Close Modal